Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: General Crude who wrote (5306)	9/15/1998 1:54:00 PM
From: Steve Fancy	Read Replies (2) \| Respond to of 6136

The press release seemed encouraging, but just the mention of AG3340 seems to send the stock down. I'm becoming more suspect that they may pull the plug on the cancer trials and focus on AMD. Based on the plans to create this oncology division, it sounds like they feel they may have something here, though if it were created tomorrow, I could see it going to zero real fast. In general, the street still appears to put no confidence in the pipeline. sf